INVA Q4 2019 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$76M-4.9% YoY

Gross Profit

$76M100.0% margin

Operating Income

$74M96.9% margin

Net Income

$46M60.5% margin

EPS (Diluted)

$0.42

QoQ Revenue Growth

+15.5%

Cash Flow

Operating Cash Flow

$67M

Free Cash Flow

$67M

Stock-Based Comp.

$488,000

Balance Sheet

Total Assets

$725M

Total Liabilities

$383M

Stockholders' Equity

$313M

Cash & Equivalents

$278M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$76M	$80M	-4.9%
Gross Profit	$76M	$80M	-4.9%
Operating Income	$74M	$77M	-4.6%
Net Income	$46M	$264M	-82.6%